Li Aihua, Fang Wei, Zuo Xiaoming, Zhang Feng, Li Weiwu, Lu Honghai, Liu Sikuan, Wang Hui, Zhang Binghui
Department of Urology, Yangpu Hospital, School of Medicine, Tongji University Shanghai, China.
Can Urol Assoc J. 2014 Nov;8(11-12):E913-5. doi: 10.5489/cuaj.2026.
We present 2 cases of urethral cancers: one is recurrent bladder transitional cell carcinoma accompanied by urethral metastatic carcinoma located on the right side of verumontanum, and the other is primary bladder and metastatic urethral adenocarcinoma. The urethral tumour was treated by transurethral holmium laser vaporization to the urethral tumour through a ureteroscope and the bladder tumour was treated with transurethral resection and degeneration of the bladder tumour (TURD-Bt). After the second or third therapy, patients were free of urethral or bladder tumour recurrence; they also did not experience urethral stricture or urinary incontinence during the 24- to 36-month follow-up. Transurethral holmium laser vaporization and TURD-Bt could be performed to treat non-invasive urethral cancer accompanied with bladder cancer and preserve the urethra and bladder.
我们报告2例尿道癌病例:1例是复发性膀胱移行细胞癌伴尿道转移癌,位于精阜右侧;另1例是原发性膀胱及转移性尿道腺癌。经输尿管镜对尿道肿瘤行经尿道钬激光汽化术,对膀胱肿瘤行经尿道切除术及膀胱肿瘤变性术(TURD-Bt)。在第二次或第三次治疗后,患者尿道或膀胱肿瘤未复发;在24至36个月的随访期间,也未出现尿道狭窄或尿失禁。经尿道钬激光汽化术和TURD-Bt可用于治疗伴有膀胱癌的非侵袭性尿道癌,并保留尿道和膀胱。